Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06428266
Other study ID # CI 09 015 008
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2021
Est. completion date July 31, 2022

Study information

Verified date May 2024
Source Instituto de Oftalmología Fundación Conde de Valenciana
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In Mexico, upper lacrimal duct obstruction (ULDO) is a common pathology, and the standard surgical treatment is closed dracryointubation. Based on statistics from our headquarters, in 30% of cases there is a failure of the technique and recurrence of symptoms due to associated complications. Because of this, the application of a self-stable bicananlicular intubation set is proposed. The aim of this study is to describe the difference in efficacy and complication rate between the application of the self-stable bicanalicular intubation set II (FCI) and closed dacryointubation in patients with ULDO .


Description:

Upper lacrimal duct obstruction (ULDO) or proximal lacrimal tract obstruction occurs when an occlusion is located in the lacrimal point, in superior and inferior canaliculi, or in the common canaliculus. When the ULDO is at the level of the canaliculi (superior, inferior or common), the alternatives available for its management are closed dacryointubation with Crowford catheter, conjunctivadacryocystorhinostomy, and bicanalicular intubation. Closed dacryointubation with Crowford tube is a technique effective in approximately 90% of children diagnosed with congenital occlusion of the lacrimal duct, however, in adults the reported surgical success rate is lower, approximately 70% according to different authors. The conjunctivadacryocystorhinostomy is the procedure proposed by many authors when there is point and canaliculi obstruction in which canalicular intubation cannot be performed due to atresia or total obstruction. The bicanaliculalr intubation with the Self-Stable Canalicular Intubation Set (FCI R), an FDA-approved silicone bicanalicular retention device, is especially indicated for the treatment of lacrimal point stenosis and horizontal canalicular obstruction. The aim of this study is to describe the difference in efficacy and complication rate between the application of the self-stable bicanalicular intubation set II (ICF) and closed dacryointubation in patients with ULDO


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date July 31, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients over 18 years of age - Patients with stenosis and incomplete obstruction of the upper lacrimal duct with epiphora > 2 on the Munk scale who have not previously undergone surgery on the affected tear duct - Patients who may undergo general anesthesia and sedation - Patients who are able to present and continue follow-up for the duration of the study - Acceptance to participate in the study by signing an informed consent Exclusion Criteria: - Patients with ocular surface involvement affecting the upper lacrimal duct, such as blepharitis with tear point epithelialization - Patients with lacrimal point malposition and/or eyelid malposition due to entropion or ectropion - Patients with congenital or acquired obstruction of the lower lacrimal duct - Patients with a history of facial paralysis - Patients with systemic inflammatory disease such as scarring pemphigoid or Steven Johnson - Patients in whom tumour involvement of the lacrimal duct is suspected - Patients with reflex tear hypersecretion due to ocular surface involvement or other causes. - Pregnancy and breastfeeding - Active infection, eye trauma, history of facial trauma with broken bones of the nose, or history of sinus surgery.

Study Design


Intervention

Device:
Bicanalicular intubation
Placement of the bicanalicular intubation set at each lacrimal point and fixed by means of its flaps at the level of the opening of the lacrimal sac.
Procedure:
Closed dacryointubation
Placement of dacryointubation tube through the canaliculus until it reaches the medial wall of the lacrimal sac and then passed the nasolacrimal duct until it empties out at the level of the inferior meatus.

Locations

Country Name City State
Mexico Institiuto de Oftalmología Fundación Conde de Valenciana Mexico City

Sponsors (1)

Lead Sponsor Collaborator
Instituto de Oftalmología Fundación Conde de Valenciana

Country where clinical trial is conducted

Mexico, 

References & Publications (4)

1. Schaefer DP. Acquired Etiologies of Lacrimal System Obstructions. In: Cohen AJ, Mercandetti M, Brazzo BG, editors. The Lacrimal System [Internet]. Springer New York; 2006 [cited 2020 Jan 15]. p. 43-65.

Fulcher T, O'Connor M, Moriarty P. Nasolacrimal intubation in adults. Br J Ophthalmol. 1998 Sep;82(9):1039-41. doi: 10.1136/bjo.82.9.1039. — View Citation

Pashby RC, Rathbun JE. Silicone tube intubation of the lacrimal drainage system. Arch Ophthalmol. 1979 Jul;97(7):1318-22. doi: 10.1001/archopht.1979.01020020060014. — View Citation

Tabatabaie SZ, Rajabi MT, Rajabi MB, Eshraghi B. Randomized study comparing the efficacy of a self-retaining bicanaliculus intubation stent with Crawford intubation in patients with canalicular obstruction. Clin Ophthalmol. 2012;6:5-8. doi: 10.2147/OPTH.S25172. Epub 2011 Dec 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Irrigation of tha lacrimal duct Irrigation of the lacrimal duct with saline solution to seek for permeability three and four months after the procedure
Primary Epiphora evidence of epiphora as told by the subject one, three and four months after surgery
Secondary Occurrence of epistaxis postoperative bleeding throug the nose one, three and four months after surgery
Secondary Presence of extrusion of bicanalicular intubation tubes extruded or non-extruded one, three and four months after surgery
Secondary How well is the positioning of the silicone tubes how well positioned or poorly positioned the tubes are one, three and four months after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00571129 - Endoscopic Dacryocystorhinostomy Prospective Research N/A
Completed NCT02851641 - Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children
Recruiting NCT04943055 - Low Temperature Plasma Ablation Combined Lacrimal Duct Catheterization in the Treatment of Lacrimal Duct Obstructive N/A
Completed NCT05999058 - Clinical Study of Lacrimal Drainage Obstruction Diseases Using Dacryoendoscopy N/A
Completed NCT03411889 - A Feasibility Study to Develop a Protocol for Functional Lacrimal Magnetic Resonance Imaging N/A
Completed NCT04931186 - Nasolacrimal Duct Obstruction
Completed NCT02636257 - A Comparative Study of Two Endoscopic Operations for Lacrimal Duct Obstruction Phase 1/Phase 2
Completed NCT03960996 - Long Term Effectiveness of Dacryocystorinostomy With and Without Bicanalicular Intubation N/A
Completed NCT01826734 - Analysis of 86 Dacryoliths at the University Hospital Ostrava N/A